Senner Christopher J.

CFO Christopher J. Senner sells 34,901 EXEL shares at $50.00 for $1,745,050; retains 952,317 shares post-transaction.

Senner sold 34,901 shares on 2026-05-18 at $50.00, reducing his holdings by 34,901 shares (-3.5% vs pre-transaction holdings) while retaining 952,317 shares post-transaction. His cross-ticker track record shows 7 prior sells with an average 90-day return of +13.1% and a 20.00% well-timed rate. At the same ticker EXEL, his 5 prior trades show inconsistent outcomes: only 1 of 5 prior sells were well-timed at the 90-day mark. The stock closed at $48.67 (current price), trading -5.7% from its 52-week high of $51.63 and +8.4% over the past 30 days. Given the company's P/E of 14.66, market cap of $12,233,451,889.61, and latest-quarter revenue of $610,812,000.00 with net income of $210,467,000.00, the CFO retains substantial equity exposure despite this discrete sale.

CFO Christopher J. Senner sells 64,895 shares in 2 transactions ($2.8M) at blended average $43.32, retaining 976,092 shares

Christopher J. Senner, EVP and CFO of Exelixis, executed 2 separate sales on 2026-02-13 and 2026-02-17, selling 64,895 shares total for $2,810,998.39 at an average price of $43.32 per share. The sale reduced his holdings by 6.2%, from 1,040,987 shares to 976,092 shares post-transaction. At the current price of $44.47, the stock has appreciated 1.2% over 30 days and 6.4% over 90 days since filing. His prior sales at Exelixis show mixed outcomes: 1 of 3 prior measurable sales was well-timed at the 90-day mark, and cross-ticker timing has been poor, with a 33.33% well-timed rate and an average 90d return of +10.9% after sales (indicating the stock typically rises after his sells). The company maintains solid fundamentals with $597.8M quarterly revenue, $193.6M net income, a P/E of 15.44, and a market cap of $11.5B. The filing does not contain flags indicating a structured trading plan, and the sales appear discretionary in nature.

CFO Senner sells 100,000 EXEL shares at $46.00 for $4.6M; stock at $45.40, up 25.6% in 30 days

Christopher J. Senner, EVP and CFO of Exelixis, sold 100,000 shares at $46.00 on 2025-05-16, representing a 9.4% reduction in his post-transaction holdings to 967.8K shares. The sale occurred near the 52-week high ($46.26), with the stock currently trading 1.9% below that peak at $45.40. The company's fundamentals remain solid, with FY revenue growth of +18.5% and a P/E of 25.22. Senner's prior trades at EXEL show mixed timing: a February 2025 sale realized a 30-day return of +2.4%, while an August 2024 sale saw a 90-day return of +31.7%, neither of which represents well-timed selling (negative 90-day returns indicate well-timed sells). The current sale's execution near the 52-week high suggests disciplined portfolio management, though the stock's recent momentum (+29.7% over 90 days) means the true test of timing will depend on forward price action.

EVP/CFO Christopher J. Senner sells 29,314 shares of EXEL at $36.14; holds 779,607 shares post-transaction

Christopher J. Senner, EVP and CFO, sold 29,314 shares at $36.14 on 2025-02-24, reducing his holdings by 3.6% to 779,607 shares. The current price stands at $37.53, near the 52-week high of $37.53, suggesting the sale occurred before a recent 14.7% surge in the last 30 days. Reviewing his cross-ticker track record, prior sells averaged +31.7% return over 90 days with a 0.00% well-timed rate, meaning the stock rose after his prior sales—indicating his past sells were poorly timed. At the same ticker (EXEL), his most recent sale on 2024-08-09 also saw the stock rise 31.7% over 90 days, extending the pattern of missed gains. The company demonstrates solid fundamentals (P/E of 13.45, +18.5% annual revenue growth, $118.0M net income), making this a modestly significant insider sale in a company showing operational strength.

CFO Christopher Senner sells 125,000 EXEL shares at $27.19; now holds 721,680 shares after reducing stake by 14.8%

Christopher Senner, EVP and CFO, executed a large open-market sale of 125,000 shares for $3.4M at $27.19 on 2024-08-09, reducing his holdings from 846.7K to 721.7K shares (-14.8%). The sale occurred near the 52-week high of $27.17, within 0.7% of peak valuations reached in 2024. At EXEL specifically, Senner's two prior sales (both in August 2023) yielded mixed timing outcomes: one showed positive 90-day return (+2.5%), while the other declined (-2.7%), with an overall 50% well-timed rate at this ticker. His cross-ticker track record across 2 prior sells shows an average 90-day return of -0.1%, also mixed. The company's fundamentals remain solid—$637.2M quarterly revenue with $226.1M net income and 13.6% annual growth—supporting a P/E of 21.93, though stock momentum has been strong (30-day +22.3%, 90-day +26.2%), potentially creating timing sensitivity for large executive liquidations.